publication venue for Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.. 47:253-259. 2005 Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk.. 48:315-321. 2005 Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.. 40:91-97. 2003
